Young rabbits are susceptible to gastrointestinal diseases caused by bacteria. Enterococcus hirae can be associated with diseases. But enterocins produced by some enterococcal species can prevent/reduce this problem. Therefore, the interaction of enterocin M with a biofilm-forming, autochthonous E. hirae Kr8 strain was tested in rabbits to assess enterocin potential in vivo. Rabbits (96), aged 35 days, both sexes, meat line M91 breed were divided into four groups, control C and three experimental groups. The rabbits in C received the standard diet, rabbits in experimental group 1 (E1) received 10 CFU/mL of Kr8, a dose 500 µL/animal/day, E2 received Ent M (50 µL/animal/day), and E3 received both Kr8 and Ent M in their drinking water over 21 days. The experiment lasted 42 days. Feces and blood were sampled at day 0/1 (at the start of the experiment, fecal mixture of 96 animals, n = 10), at day 21 (five fecal mixtures per group, n = 5), and at day 42 (21 days after additives cessation, the same). At days 21 and 42, four rabbits from each group were slaughtered, and cecum and appendix were sampled for standard microbial analysis. Ent M showed decreased tendency of Kr8. Using next-generation sequencing, the phyla detected with the highest abundance were Firmicutes, Verrucomicrobia, Bacteroidetes, Tenericutes, Proteobacteria, Cyanobacteria, Saccharibacteria, and Actinobacteria. Interaction of Ent M with some phyla resulted in reduced abundance percentage. At day 21, significantly increased phagocytic activity (PA) was found in E1 and E2 (p < 0.001). Kr8 did not attack PA and did not stimulate oxidative stress. But Ent M supported PA. The prospective importance of this study lies in beneficial interaction of enterocin in host body.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12602-022-09941-5DOI Listing

Publication Analysis

Top Keywords

enterococcus hirae
8
hirae kr8
8
kr8 strain
8
µl/animal/day received
8
rabbits
7
kr8
5
enterocin interaction
4
interaction broiler
4
broiler rabbits
4
rabbits autochthonous
4

Similar Publications

, a rare human pathogen, has limited clinical data. This case report presents a case of sepsis, pyelonephritis, and septic spondylitis treated successfully with ampicillin. An 82-year-old woman was hospitalized for acute pyelonephritis and sepsis, presenting with fever and abdominal pain.

View Article and Find Full Text PDF

In recent years, reports of infections in humans have increased. Similarly to most known Enterococci, has been identified mostly in bacteremia, urinary tract infections, infective endocarditis, and biliary tract infections. We present a case of bacteriemia associated with traumatic soft tissue infection in a 77-year-old male patient, a polytrauma victim with a tibia-fibula open fracture after a forklift accident.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the fermentation of sea cucumber intestine polysaccharides using GS22 to enhance extraction and biological properties.
  • GS22 fermentation improved extraction yield from 0.48% to 0.63%, decreased molecular weight, and altered monosaccharide composition.
  • Fermented polysaccharides (SC-PF) demonstrated superior antioxidant and enzyme inhibition abilities compared to non-fermented polysaccharides (SC-P), indicating better prebiotic potential.
View Article and Find Full Text PDF

Antibiotic therapy has been the most popular line of treatment for the control of mastitis worldwide during the last few decades. Alternative and sustainable treatments must be developed because pathogens are becoming more resistant to antibiotics, leading to the development and spread of antimicrobial resistance (AMR). The aim of the current investigation was to isolate lactic acid bacteria (LAB) with probiotic potential that can inhibit mastitis-causing pathogens to prevent bovine mastitis.

View Article and Find Full Text PDF

Oncotherapy can shape intestinal microbiota, which, in turn, may influence therapy effectiveness. Furthermore, microbiome signatures during treatments can be leveraged for the development of personalised therapeutic protocols in cancer treatment based on the identification of microbiota profiles as prognostic tools. Here, for the first time, the trajectory of gut and salivary microbiota in a patient treated with Larotrectinib, a targeted therapy approved for diagnosed glioblastoma multiforme neurotrophic tyrosine receptor kinase () gene fusion-positive, has been accurately investigated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!